Companies Cryptocurrencies
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
Exchange: NasdaqGM
IPO Date: 18/07/2019
CEO: Dr. Robert Gould
Biotechnology Healthcare 🔗
  • FULC
  • 23.47
  • 955071744
    market cap
  • -0.23000145
If you bought

shares of Fulcrum Therapeutics Inc (FULC) on
You would have made
Old Price $12 Current Price $12

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 62 full-time employees. The firm focuses on improving the lives of patients with genetically defined rare diseases. The firm have developed a product engine which identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The firm is also engaged in developing drugs for the treatment for the root cause of muscle disorders, central nervous system disorders and blood disorders.

Address: 26 Landsdowne St Cambridge MASSACHUSETTS 02139

Stay updated.